Dr. QINGHUI CHENG | Academic Recognition | Best Researcher Award

Dr. QINGHUI CHENG, Guangxi Academy of Sciences, China

Dr. Qinghui Cheng is an Assistant Researcher at the Guangxi Academy of Sciences, China. He earned his Ph.D. in Physical Chemistry from the State University of New York at Binghamton and completed postdoctoral training at Michigan State University. His research focuses on the molecular structure of membrane-associated β-amyloid fibrils in various membrane environments, with a particular emphasis on Alzheimer’s disease. Utilizing solid-state NMR spectroscopy, he has made significant contributions to understanding membrane-protein interactions, fungal and plant cell-wall architectures, and structure-based drug screening. Dr. Cheng has co-authored multiple high-impact publications in Nature Communications, Journal of Biological Chemistry, and Biomolecules.

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Qinghui Cheng’s journey into the world of molecular biophysics and structural chemistry began with a strong foundation in the chemical sciences. He completed his Master’s training at Peking University (2011–2014), one of China’s premier institutions, where he first developed an interest in structural biology and peptide chemistry. His academic curiosity led him to pursue a Ph.D. in Physical Chemistry at the State University of New York at Binghamton (2015–2020). Under the guidance of Dr. Wei Qiang, Dr. Cheng focused on unraveling the complex structures of amyloid peptides and their interaction with lipid membranes using solid-state NMR spectroscopy.

🧪 Professional Endeavors

Dr. Cheng’s professional career has spanned multiple leading institutions. From 2020 onwards, he served as a teacher and researcher at the Key Laboratory of Modern Chinese Medicine Preparations under the Ministry of Education at Jiangxi University of Chinese Medicine. His role bridged traditional Chinese medicine with cutting-edge biochemical research, expanding the scope of pharmacological studies through modern analytical techniques. In 2022, he began a prestigious Postdoctoral Research Associate position in the Chemistry Department at Michigan State University, where he joined Dr. Tuo Wang’s lab. His work there focused on the solid-state NMR-based structural analysis of β-amyloid fibrils and fungal cell-wall polysaccharides. In 2024, he was appointed as an Assistant Researcher at the Guangxi Academy of Sciences, marking a return to China with a strong portfolio of international research.

🔬 Contributions and Research Focus

Dr. Cheng has made substantial contributions to understanding membrane-associated β-amyloid fibrils, particularly their behavior in various lipid environments—critical for Alzheimer’s research. His investigations employed a mix of solid-state NMR spectroscopy, circular dichroism, fluorescence spectroscopy, and toxicity assays to examine how different amyloid structures impact neuronal cell health. In a groundbreaking study, he determined the molecular structure of a β-amyloid fibril with the highest observed toxicity to N2a neuronal cells, shedding light on the structural basis of neurotoxicity. He also led efforts to extract and analyze plasma membrane components from rat brains across different ages, paving the way for age-related studies in lipidomics and neurodegeneration. Apart from neuroscience, Dr. Cheng worked on fungal cell-wall architecture, notably the structure of chitin and chitosan in Rhizopus delemar, contributing to a Nature Communications publication. His research extended to softwood lignin-carbohydrate complexes, enhancing understanding of plant biomass for bioenergy applications. He also collaborated with Tsinghua University to develop porous materials capable of capturing radioactive iodine (I-131), a critical advancement in nuclear waste management and future nuclear energy systems.

🏅 Accolades and Recognition

Dr. Cheng’s contributions have been recognized through co-first authorship and lead authorship in high-impact journals such as Nature Communications, Journal of Biological Chemistry, Carbohydrate Polymers, Biomolecules, and BBA-Biomembranes. His multidisciplinary approach has won him praise for both depth and innovation in biochemical research, particularly in using solid-state NMR as a screening tool for Alzheimer’s drug development—an approach applied for the first time under his guidance.

🌍 Impact and Influence

Dr. Cheng’s work stands at the intersection of neuroscience, structural biology, and material science, influencing several key areas:

• Advancing understanding of neurodegenerative diseases

• Enabling structure-based drug discovery

• Contributing to nuclear waste safety

• Supporting sustainable bioenergy research through plant cell-wall analysis

His methodical research on β-amyloid fibrils not only deepens scientific understanding of AD pathology but also provides strategic frameworks for targeted drug screening. Moreover, his fungal and plant cell-wall studies have practical implications in both medicine and energy sectors.

🌟 Legacy and Future Contributions

As Dr. Qinghui Cheng transitions into a new role at the Guangxi Academy of Sciences, he is poised to become a leader in the next generation of structure-guided therapeutic development and bioanalytical innovation. His ongoing research will likely focus on:

• Elucidating molecular mechanisms of neurodegenerative diseases

• Designing selective inhibitors based on structural data

• Integrating traditional Chinese medicine with modern molecular insights

• Expanding environmental safety applications of porous materials

Dr. Cheng’s legacy is one of interdisciplinary synthesis, scientific rigor, and innovation. With a strong publication record, international training, and a forward-looking research agenda, he is well-positioned to make transformative contributions in the fields of biophysics, chemistry, and biomedical sciences in the years ahead.

✍️Notable Publications